For the quarter ending 2026-03-31, YBGJ has $709,872 in assets. $3,019,451 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Intangible assets, net | - | - | 43,241 | 44,653 |
| Due from related parties | - | - | - | 282,617 |
| Cash | 10,382 | 8,062 | 10,926 | 10,416 |
| Receivables | 134,220 | 138,043 | 114,287 | 118,006 |
| Prepaid expenses | 136,196 | 209,316 | 202,054 | 210,413 |
| Inventory | 24,414 | 24,034 | 37,889 | 37,650 |
| Due from related parties | 292,611 | 288,057 | 284,407 | - |
| Total current assets | 597,823 | 667,512 | 649,563 | 659,102 |
| Property and equipment, net | 17,761 | 43,030 | 84,645 | 126,007 |
| Intangible assets, net | 39,175 | 42,080 | - | - |
| Operating lease right of use asset | 39,215 | 78,783 | 138,604 | 184,943 |
| Lease security deposit | 15,898 | 15,689 | 37,158 | 36,863 |
| Total assets | 709,872 | 847,094 | 953,211 | 1,051,568 |
| Accounts payable and accrued expenses (including accounts payable and accrued expenses of vie without recourse to the company of 1,123,073 and 1,008,758 of march 31, 2026 and december 31, 2025, respectively) | 1,104,795 | 1,060,730 | 957,197 | 1,050,497 |
| Advances from prospective customers/distributors (including advances from prospective customers/distributors of vie without recourse to the company of 447,306 and 440,344 as of march 31, 2026, and december 31, 2025, respectively) | 447,306 | 440,344 | 434,765 | 432,028 |
| Due to related parties (including due to related parties without recourse to the company of 1,278,067 and 1,061,372 as of march 31, 2026 and december 31, 2025, respectively) | 1,428,135 | 1,211,440 | 1,024,750 | 3,365,814 |
| Operating lease liabilities - current (including operating lease liabilities - current of vie without recourse to the company of 39,215 and 78,783 as of march 31, 2026 and december 31, 2025, respectively) | 39,215 | 78,783 | 138,604 | 177,131 |
| Total current liabilities | 3,019,451 | 2,791,297 | 2,555,316 | 5,025,470 |
| Operating lease liabilities - non-current (including operating lease liability - non- current of vie without recourse to the company of 197,202 and 197,202 as of december 31, 2025 and december 31, 2024, respectively) | - | 0 | 0 | 7,812 |
| Total liabilities | 3,019,451 | 2,791,297 | 2,555,316 | 5,033,282 |
| Preferred stock, par value .01 per share, 5,000,000 shares authorized, none issued | 0 | - | - | 0 |
| Common stock, value-Common Stock Class B | - | - | - | 4 |
| Common stock, value-Common Class A | 170,416 | 170,416 | 124,876 | - |
| Common stock, value-Common Stock Class A | - | - | - | 119,816 |
| Common stock, value-Common Class B | 4 | 4 | 4 | - |
| Additional paid in capital | 5,468,883 | 5,468,883 | 5,514,423 | 2,989,483 |
| Accumulated deficit | -8,012,667 | -7,740,059 | -7,478,641 | -7,326,775 |
| Accumulated other comprehensive income (loss) | 75,749 | 146,100 | 176,450 | 217,229 |
| Total deficit attributable to common shareholders | -2,297,615 | -1,954,657 | -1,662,888 | -4,000,243 |
| Non-controlling interests | -11,964 | 10,454 | 60,783 | 18,529 |
| Total deficit | -2,309,579 | -1,944,203 | -1,602,105 | -3,981,714 |
| Total liabilities and shareholders' equity | 709,872 | 847,094 | 953,211 | 1,051,568 |
Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)